High U.S. Health Prices from Market Power?
The Independent Institute: U.S. hospitals are buying up each other, reducing competition and raising prices, warns NCPA Senior Fellow John R. Graham in a commentary at The Independent Institute.
Senator Cassidy's King v. Burwell Obamacare Alternative Should Be A Winner
Forbes: “Under Obamacare, net premiums are artificially low because of tax credits that are consumed by health insurers,” says NCPA Senior Fellow John R. Graham in a Forbes commentary.
Doctors Beware: the Electronic Health Records Debacle May Get Much Worse
American Thinker: Doctors are accepting fines from Medicare & Medicaid Services for not complying with electric health records (EHR) regulations because the records are taking time away from patients, says NCPA Senior Fellow John R. Graham in an American Thinker commentary.
Obamacare’s Enrollment Success Disguises More Fragmented Coverage and Care
Atlanta Journal-Constitution: The 11.7 million enrollments cheered by Obamacare’s supporters will drop as people fail to pay their premiums, switch insurance, and drop their coverage, warns NCPA Senior Fellow John R. Graham in a commentary in the Atlanta Journal-Constitution.
Obamacare’s Risk Corridors Are Back, and Bigger and Badder than Ever!
The Independent Institute: Obamacare’s risk corridors which comprised an unlimited taxpayer bailout of insurers’ profits have been capped by Congress, says Senior Fellow John R. Graham in a commentary at The Independent Institute.
Health Plans' Mastery of Obamacare Poses Challenge To Repeal
Forbes: Convincing health plans that there is an alternative better than Obamacare is not easy, but not impossible, said NCPA Senior Fellow John R. Graham in a Forbes commentary.
Chief Actuary Blows Away Make-Believe Medicare 'Doc Fix'
Forbes: The Medicare “doc fix” offers little reward, but lots of risk to physicians and taxpayers alike, cautions NCPA Senior Fellow John R. Graham in a Forbes commentary.
Kick the Medicare Doc Fix Down the Road
Forbes: Kicking the Medicare Sustainable Growth Rate issue down the road at least keeps the issue on Congress’s radar, says NCPA Senior Fellow John R. Graham in a Forbes commentary.
Government and the Private Sector – A Case Study
Townhall: Government should be encouraging the private sector, not attempting to innovate on its own, said NCPA President/CEO Allen West and Senior Fellow John R. Graham in a Townhall commentary.
Administration Should Fully Disclose Risks to Enrollees in Obamacare Exchanges
The Hill: The Obama administration needs to disclose fairly and fully the exact nature of the legal risk that people are taking when they apply for coverage in one of the 36 states without their own health-insurance exchange, says NCPA Senior Fellow John R. Graham in a commentary at The Hill.
How Domestic Medical Tourism Could Save Us All Money
The Washington Post: Seniors on Medicare can get quality care at a reasonable price by engaging in “domestic medical tourism,” says NCPA Senior Fellow John R. Graham in a commentary at The Washington Post.
Get the Federal Government Out of the Electronic Health Records Business
American Thinker: The $30 billion the federal government put towards getting doctors and hospitals to take up electronic health records did more damage than good, says NCPA Senior Fellow John R. Graham in an American Thinker commentary.
Relax: The FDA Will Not Regulate Things That Increase The Flow Of Your Qi
Forbes: The laws governing medical devices are poorly written and give the FDA too much power, says NCPA Senior Fellow John R. Graham in a Forbes commentary.
Under Obamacare, Will America Keep Winning The War On Cancer?
Forbes: Restricting access to oncologists and cancer drugs under Obamacare4 will severely disadvantage Americans in the war on cancer, says NCPA Senior Fellow John R. Graham in a Forbes commentary.
How To Get A Medicaid Work Requirement? Bundle It With Paul Ryan's Opportunity Grants
Forbes: Bundling Medicaid alongside other safety-net funding into Paul Ryan’s Opportunity Grants would unleash civic entrepreneurship at the local level while reducing the burden on taxpayers, according to a Forbes commentary.
Digital Health Venture Funding Doubled In 2014
Forbes: Congress needs to clarify the FDA’s authority over emerging health technologies, says NCPA Senior Fellow John R. Graham in a Forbes commentary.
Crisis In Pharma R&D: It Costs $2.6 Billion To Develop A New Medicine; 2.5 Times More Than In 2003
Forbes: The cost of making a new medication is growing astronomically – and hurting patients’ premiums, says NCPA Senior Fellow John R. Graham in a Forbes commentary.
Medicare Should Adopt A 'Lock In' Policy
Forbes: Devon Herrick is right: Medicare should adopt a ‘Lock-In’ policy, says NCPA Senior Fellow John R. Graham in a Forbes commentary.
Mars and Venus on Medicaid
Forbes: Medicaid managed care strikes a balance between Medicaid “ghetto” and private choice, and is a good reform while Obamacare is still in place, says NCPA Senior Fellow John R. Graham in a Forbes commentary.
John R. Graham – Commentaries
John R. Graham is a Senior Fellow at the Independent Institute as well as NCPA. As an expert on individual choice and limited government control over medicine, Graham speaks frequently …
The Return of Death Panels? Government-Funded End-of-Life Planning is Morally Questionable
Forbes: Letting the government pay doctors to counsel patients on end-of-life issues is risky, says NCPA Senior Fellow John R. Graham in a Forbes commentary.
Are Patents Leading To Drugs That Cure The Wrong Patients?
Forbes: The FDA, not the patent system, should be the first reform to improve the benefits of pharmaceutical R&D, says NCPA Senior Fellow John R. Graham in a Forbes commentary.